C
Curate Biosciences
Transforming the process of purifying and enriching cells for cell therapy production
About Curate Biosciences
Curate Biosciences, formerly known as GPB Scientific, is a life sciences company focused on transforming cell therapy manufacturing. Founded in 2002, with dedicated work on its primary system beginning in 2016, the company operates with facilities in Carlsbad, California. The name change from GPB Scientific, which stood for 'getting people better,' to Curate Biosciences was a strategic move to better reflect the company's core mission of providing high-quality cells for therapeutic use.
The company was founded by Mike Grisham, who also serves as Chairman. Initially, the firm and its spinoffs developed various devices for the microfluidics field, with an early focus on prenatal diagnostics. The pivot towards cell and gene therapy capitalizes on this deep experience. The business targets biopharmaceutical companies, contract manufacturers (CDMOs), and academic research centers involved in developing cell therapies like CAR-T. Its business model centers on selling its proprietary cell processing system and the associated single-use cartridges required for its operation.
The flagship product is the Curate® Cell Processing System, a benchtop instrument that automates cell separation. It utilizes a proprietary microfluidic technology called Deterministic Cell Separation™ (DCS), which gently sorts cells based on size. This method is exceptionally efficient, recovering about 90% of white blood cells from a patient's blood product while eliminating over 90% of red blood cells and 99% of platelets. The key benefit is the delivery of a cleaner, larger, and healthier quantity of starting cells, a critical bottleneck in manufacturing gene and cell therapies. By improving the quality of this initial material, the system can reduce the overall cost of autologous cell therapy production by up to 50% and shorten the time needed to create a patient-specific dose. The system is designed for ease of use, processing a standard blood cell unit in approximately 45 minutes with minimal hands-on time.
Source: Dealroom company dataAt a glance
- Status
- Operational
- Founded
- 2012
- Headquarters
- Carlsbad, United States
- Employees
- 3
- Open positions
- None listed
- Dealroom signal
- 65.5/100
- Industry
- Health
- Sub-industry
- BioTechnology
- Sector
- Biotech & Life Sciences, Biotechnology, Spinout, Biotech and Pharma, DT and LS, science-based
- Business model
- Manufacturing
- Client focus
- b2b
Knowledge graph
More headlines
Funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| LATE VCEquity / VC | May 2021 | $18M | $72M | Amgenbd · Vensana Capital | — |
| LATE VC✓Equity / VC | Apr 2020 | $26M | $102M | Vensana Capital · Amgen Ventures | ↗ |
Growth signals
Latest recorded traffic for Curate Biosciences is 200 monthly website visits, up 17.6% over the last three months. Curate Biosciences's team grew 0% over the past year.
Similar companies
Company identity and context are open; selected comparison metrics preview what is available on the platform.
Investments and acquisitions
Recent portfolio relationships for companies that also act as investors or acquirers.
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Series B and later3 investors entered at this stage
Vensana Capital
Amgen Ventures
Amgenbd
Other known investors2 additional known investors
Princeton University
Small Business Innovation Research
Source: Dealroom Talent Intelligence.
Global footprint
Market sentiment
An AI-synthesised read of the highest-engagement posts about Curate Biosciences on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Curate Biosciences’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.







